278 related articles for article (PubMed ID: 27585549)
1. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
2. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
Zheng W; Cao XL; Ungvari GS; Xiang YQ; Guo T; Liu ZR; Wang YY; Forester BP; Seiner SJ; Xiang YT
PLoS One; 2016; 11(6):e0156510. PubMed ID: 27285996
[TBL] [Abstract][Full Text] [Related]
5. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Topiramate for atypical antipsychotic-induced body weight gain and metabolic adversities: a systematic review and meta-analysis].
Liang H; Li H; Hu Y; Li S; Lü L; Song X
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):216-23. PubMed ID: 26879726
[TBL] [Abstract][Full Text] [Related]
7. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
[TBL] [Abstract][Full Text] [Related]
8. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Yang XH; Li L; Zhang QE; Ng CH; Ungvari GS; Li XB; Ning YP; Xiang YT
J Psychiatr Res; 2018 Aug; 103():244-251. PubMed ID: 29906709
[TBL] [Abstract][Full Text] [Related]
9. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
Wang G; Zheng W; Li XB; Wang SB; Cai DB; Yang XH; Ungvari GS; Xiang YT; Correll CU
J Psychiatr Res; 2018 Oct; 105():23-32. PubMed ID: 30144667
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.
Galling B; Roldán A; Rietschel L; Hagi K; Walyzada F; Zheng W; Cao XL; Xiang YT; Kane JM; Correll CU
Expert Opin Drug Saf; 2016 May; 15(5):591-612. PubMed ID: 26967126
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
Zheng W; Zheng YJ; Li XB; Tang YL; Wang CY; Xiang YQ; de Leon J
J Clin Psychopharmacol; 2016 Dec; 36(6):628-636. PubMed ID: 27755219
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.
Correll CU; Sheridan EM; DelBello MP
Bipolar Disord; 2010 Mar; 12(2):116-41. PubMed ID: 20402706
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
[TBL] [Abstract][Full Text] [Related]
16. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Xiang YT
Eur Neuropsychopharmacol; 2018 Jan; 28(1):149-158. PubMed ID: 29174529
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
